Five-year review

for the year eneded 30 September 2016

Rm 2016       Restated
2015
*# 2014 ** Restated
2013
^** 2012 **
Consolidated income statements                        
Revenue 31 738       28 690   30 126   27 065   22 771  
Profit before taxation, income from associates, abnormal items and impairments 3 978       3 823   3 155   2 721   3 356  
Income from associates 861       603   597   515   416  
Abnormal items and impairments (324)       (339)   (1 056)   (2)   5  
Profit before taxation 4 515       4 087   2 696   3 234   3 777  
Taxation (1 221)       (977)   (832)   (837)   (1 029)  
Profit for the year from continuing operations 3 294       3 110   1 864   2 397   2 748  
Attributable to (continuing operations):                        
Owners of the parent 3 261       3 122   1 991   2 516   2 718  
Non-controlling interests 33       (12)   (127)   (119)   30  
Consolidated statements of financial position                        
Property, plant and equipment 4 542       4 641   5 868   5 499   3 359  
Goodwill and intangible assets 3 941       4 233   4 527   5 424   4 012  
Investments 4 905       4 312   3 422   3 413   2 655  
Current assets 11 099       11 617   10 728   9 486   7 783  
Assets classified as held for sale –       –   –   1 281   –  
Total assets 24 487       24 803   24 545   25 103   17 809  
Issued capital and reserves before share-based payment reserve 15 059       13 407   12 753   12 423   10 970  
Share-based payment reserve 489       424   425   364   332  
Non-controlling interests 487       (53)   770   1 028   393  
Deferred taxation liability/(asset) 211       150   (28)   225   250  
Provision for post-retirement medical aid 666       643   626   581   407  
Long-term borrowings 1 069       1 215   627   1 453   235  
Current liabilities 6 506       9 017   9 372   8 330   5 222  
Liabilities classified as held for sale –       –   –   699   –  
Total equity and liabilities 24 487       24 803   24 545   25 103   17 809  
Consolidated cash flow statements                        
Cash operating profit after interest and taxation 3 432       2 841   3 168   2 915   3 048  
Working capital changes (604)       (812)   (348)   (337)   (592)  
Dividends received 406       326   287   301   176  
Cash available from operations 3 234       2 355   3 107   2 879   2 632  
Dividends and capital distributions paid (1 661)       (1 643)   (1 467)   (1 426)   (1 318)  
Net cash flow from operating activities 1 573       712   1 640   1 453   1 314  
Net cash flow from investing activities 115       (1 056)   (415)   (3 282)   (732)  
Net cash flow before financing activities 1 688       (344)   1 225   (1 829)   582  
Net cash flow from financing activities (562)       76   (1 109)   426   (297)  
Net increase/(decrease) in cash and cash equivalents 1 126       (268)   116   (1 403)   285  
* The 2015 comparatives have been restated for the retrospective reclassification relating to the treatment of foreign exchange profits and losses on foreign cash and bank balances previously included in operating income/(loss) and now reclassified to net finance costs. Refer to annual financial statements for further details.
** Not restated for the exclusion of TBCG.
# Income statement restated as required by IFRS 5 in relation to the treatment of Tiger Branded Consumer Goods plc (TBCG) as a discontinued operation.
^ The amounts have been restated due to the adoption of IAS 19R.